PMID: 7013296Jan 15, 1981Paper

Cholinergic regulation of insulin and glucagon secretion in healthy people and in patients with non-insulin dependent diabetes

Zeitschrift für die gesamte innere Medizin und ihre Grenzgebiete
A CzyzykD Strycek-Kaminska

Abstract

In 10 healthy subjects and in 10 patients with non-insulin-dependent, well controlled diabetes the following three tests were carried out in each persons: 1. the intravenous infusion of 25 g of L-arginine over 30 min, 2. the intravenous infusion of L-arginine plus prostigmin (0.01 mg per kg body weight), and 3. the intravenous infusion of L-arginine plus atropine (0.01 mg per kg body weight). Venous blood glucose, plasma insulin (IRI) and plasma glucagon (IRG) were determined on fasting and throughout the tests. The cholinergic stimulation increased, and the cholinergic blockade decreased the insulin and glucagon secretion during intravenous L-arginine infusion, both in healthy subjects and in diabetics, these effects being less marked (not significantly) in the latter group of test persons. On the other hand, neither prostigmin, nor atropine modified the behavior of blood glucose in comparison to the course of glycaemia observed during the infusion of L-arginine alone. These observations are an evidence of an integrative effect of the cholinergic system on the function of A- and B-cells of the pancreatic islets, which may be of importance for the proper utilization of food substrates.

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.